Lilly to test combinations with Merck, Bristol-Myers’ cancer drugs

(Reuters) – Eli Lilly & Co signed two separate deals with Merck & Co Inc and Bristol-Myers Squibb Co to test combinations of its cancer treatments with two recently approved therapies that belong to a promising new class of drugs. Lilly will test its treatments – approved and experimental – in combination with PD-1 inhibitors Keytruda and Opdivo. The treatments are designed to help the body’s own immune system fight cancer by blocking a protein called Programmed Death receptor (PD-1). Bristol-Myers’ Opdivo was approved by the U.S. Food and Drugs Administration on Dec. 22. …
Go to Source

FDA seeks more safety data on Antares testosterone drug

A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring(Reuters) – Antares Pharma Inc said the U.S. Food and Drug Administration has asked for additional safety data on its testosterone drug after a patient developed hives in a mid-stage trial. Antares' shares fell 7.6 pct in premarket trading on Tuesday on concerns that the regulator's request could delay the company's marketing application for the drug. The FDA has become more cautious about approving testosterone drugs after it found late last year that more than a fifth of the patients prescribed such drugs did not get their testosterone levels tested before or during treatment. …

Go to Source

Sport England launches fitness campaign to encourage women to take up sport and exercise

This Girl Can campaign aims to dispel belief that exercise is for those already fit, skilled and thin Sport England has launched a marketing campaign to encourage more women to take up sport and physical exercise, backed by celebrities including Clare Balding, Dame Kelly Holmes and Sally Gunnell. This Girl Can kicks off with a TV ad launching during ITV’s Coronation Street on Monday night …
Go to Source

1 35 36 37 38 39 59